Abstract：Objective To investigate the effect of Lipopitride combined with Atorvastatin in the treatment of patients with coronary heart disease with hyperlipidemia.Methods A total of 103 patients with coronary heart disease and hyperlipidemia admitted to People′s Hospital of Yunyang District in Shiyan City from July 2018 to July 2019 were selected,and they were divided into Atorvastatin group (n=51) and combined treatment group (n=52) by random digital table method.Atorvastatin group was treated with Atorvastatin orally in the basic treatment,the combined treatment group was treated with Lipopitride combined with Atorvastatin.The control conditions of total cholesterol (TC),triacylglycerol(TG),low-density lipoprotein cholesterol (LDL-C),high-density lipoprotein cholesterol (HDL-C) were compared between the two groups,the levels of hypersensitive C reactive protein (hs-CRP) before and after treatment were measured and compared between the two groups,the adverse reactions of patients during medication were observed.Results The TC、TG、LDL-C control compliance rates in the combined treatment group were higher than those in the atorvastatin group (P＜0.05).There was no significant difference in HDL-C control compliance rate between the two groups(P＞0.05).After treatment,the hs-CRP of both groups was lower than that before treatment,and the hs-CRP of the combined treatment group was lower than that of Atorvastatin group (P＜0.05).The total adverse reaction rate in the combined treatment group was 5.77%,which was lower than 19.61% in the Atorvastatin group (P＜0.05).Conclusion Patients with coronary heart disease and hyperlipidemia treated with Lipopitride combined with Atorvastatin can play a better lipid-lowering effect,improve their blood lipid indicators,and reduce hs-CRP levels.
张成龙. 脂必泰联合阿托伐他汀治疗冠心病合并高脂血症的效果[J]. 中国当代医药, 2021, 28(1): 78-80.
ZHANG Cheng-long. Effect of Lipidetine combined with Atorvastatin in the treatment of coronary heart disease with hyperlipidemia. 中国当代医药, 2021, 28(1): 78-80.
京公网安备 11010502046607号